troglitazone has been researched along with Carcinoma, Epidermoid in 6 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakashiro, K | 1 |
| Begum, NM | 1 |
| Uchida, D | 1 |
| Kawamata, H | 1 |
| Shintani, S | 1 |
| Sato, M | 1 |
| Hamakawa, H | 1 |
| Fukuchi, K | 1 |
| Date, M | 1 |
| Azuma, Y | 1 |
| Shinohara, M | 1 |
| Takahashi, H | 1 |
| Ohura, K | 1 |
| Hashimoto, Y | 1 |
| Shimada, Y | 1 |
| Itami, A | 1 |
| Ito, T | 1 |
| Kawamura, J | 1 |
| Kawabe, A | 1 |
| Kaganoi, J | 1 |
| Maeda, M | 1 |
| Watanabe, G | 1 |
| Imamura, M | 1 |
| Takashima, T | 2 |
| Fujiwara, Y | 2 |
| Hamaguchi, M | 1 |
| Sasaki, E | 1 |
| Tominaga, K | 1 |
| Watanabe, T | 1 |
| Oshitani, N | 1 |
| Higuchi, K | 2 |
| Arakawa, T | 2 |
| Yano, Y | 1 |
| Hasuma, T | 1 |
| Otani, S | 1 |
| Rumi, MA | 1 |
| Sato, H | 1 |
| Ishihara, S | 1 |
| Ortega, C | 1 |
| Kadowaki, Y | 1 |
| Kinoshita, Y | 1 |
6 other studies available for troglitazone and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Thiazolidinediones inhibit cell growth of human oral squamous cell carcinoma in vitro independent of peroxisome proliferator-activated receptor gamma.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Chromans; DNA Mutational Analysis; Humans; Mouth Neoplas | 2003 |
Apoptosis in human oral squamous cell carcinomas is induced by 15-deoxy-delta 12,14-prostaglandin J2 but not by troglitazone.
Topics: Amino Acid Chloromethyl Ketones; Analysis of Variance; Antineoplastic Agents; Apoptosis; Carcinoma, | 2003 |
Growth inhibition through activation of peroxisome proliferator-activated receptor gamma in human oesophageal squamous cell carcinoma.
Topics: Alitretinoin; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blotting, Weste | 2003 |
Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
Topics: Antibodies, Monoclonal; Apoptosis; Barrett Esophagus; Biopsy; Bisbenzimidazole; Blotting, Western; C | 2005 |
PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell | 2001 |
Growth inhibition of esophageal squamous carcinoma cells by peroxisome proliferator-activated receptor-gamma ligands.
Topics: Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Chromans; DNA Replication; Esophageal Neoplasms | 2002 |